Arch Therapeutics (ARTH) PT Raised to $3 at Roth Capital
Tweet
Share
E-mailGet Alerts ARTH Hot Sheet
Price: $0.16 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
Roth Capital analyst David Solomon raised the price target on Arch Therapeutics (OTC: ARTH) to $3.00 (from $2.10) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Nordea Bank Abp (NDA:SS) (NRDBY) to Equalweight
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Morgan Stanley Upgrades Swedbank (SWEDA:SS) (SWDBY) to Equalweight
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
